Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes Approval based on the TN-10 phase 2 study that demonstrated a significant delay of onset of stage 3 T1D in stage 2 T1D ...
Sanofi's Teizeild approved in the EU for patients with stage 2 type 1 diabetes Approval based on the TN-10 phase 2 study that demonstrated a significant delay of onset of stage 3 T1D in stage 2 T1D ...
If approved, lecanemab may become the first and only anti-amyloid treatment in China to offer an at-home injection from the ...
PCMag Australia on MSN
I Investigated Every Windows 12 Clue. These Are the Features I'm Betting Will Actually Arrive
Microsoft hasn't confirmed Windows 12 yet, but leaked code, insider previews, and the latest Copilot+ PC updates hint at ...
BURTON, MI, UNITED STATES, January 9, 2026 /EINPresswire.com/ -- Javelin Sciences, a CLIA-certified biotechnology ...
Anthropic is pushing into the healthcare market as it launches artificial intelligence tools and resources purpose-built for ...
Sanofi’s Tzield accepted for priority review in the US for young children with stage 2 type 1 diabetesIf approved, Tzield would be the first ...
Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...
OmniOutliner 6 offers multiple powerful improvements and new features that will make any outlining task even more streamlined ...
While a lot of people (yes, even adults) think of vegetables as a bummer, there is a whole lot of science behind their health ...
US FDA accepts for priority review for Sanofi’s sBLA for Tzield for young children with stage 2 type 1 diabetes: Paris Tuesday, January 6, 2026, 12:00 Hrs [IST] The US Food and ...
Anthropic launches Claude for Healthcare, expanding AI tools for clinicians, insurers, and patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback